Free Trial
LON:EDX

Edx Medical Group Final Earnings Results & Report

GBX 9.20 +0.45 (+5.14%)
As of 11:54 AM Eastern

Edx Medical Group reported Final earnings on September 3, 2026. The company reported EPS of -GBX 1.50.

Earnings Announcement Details

Quarter
Final
Time
Before Market Opens

Edx Medical Group EPS Results

Actual EPS
-GBX 1.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Edx Medical Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Edx Medical Group Final Earnings FAQ

Edx Medical Group (LON:EDX) reported earnings of -GBX 1.50 per share for Final. The report was announced on Thursday, September 3, 2026.

Edx Medical Group Earnings Headlines

No headlines for this company have been tracked by MarketBeat.com
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Edx Medical Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edx Medical Group and other key companies, straight to your email.

About Edx Medical Group

Edx Medical Group (LON:EDX) plc is a United Kingdom-based medical diagnostics company focused on developing and commercializing clinical tests intended to support the detection, diagnosis and management of disease. Its work is centered on molecular and genetic testing, with an emphasis on providing more personalized information to healthcare professionals and patients.

The company’s activities include the development of diagnostic and screening products for applications such as cancer and other significant health conditions. Its testing approach is designed to analyze biological and genetic information that may help inform clinical decisions, including disease assessment and treatment selection.

EDX Medical Group serves the healthcare and life sciences markets, primarily through its United Kingdom operations. The company is listed on the London Stock Exchange and is focused on advancing diagnostic technologies from development toward use in clinical settings.

View Edx Medical Group Profile